LSI:FRA
CK Life Sciences Intl (Holdings) Inc
€0.060
arrow_downward
-0.83%(-0.00050) 1D
Nov 13, 8:03:28 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSI...
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
Open
€0.06
High
€0.06
Low
€0.06
Mkt. cap
5.14B
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.11
52-wk low
€0.05
No. of employees
2K
News stories
From web sources and news partners
Bloomberg.com
·
18 minutes ago
Goldman Sees S&P 500 Rising 14% on Cheap Hyperscaler Valuations
www.marketscreener.com
·
4 minutes ago
Gold rebounds but heads for weekly fall before US inflation data
Benzinga
·
33 minutes ago
Stock Market Today: Dow Jones, S&P 500 Futures Rise, Nvidia CEO Exit Remains in Focus — CSCO, AMAT, NU in
Traders Union
·
8 hours ago
Bitcoin underperforms gold and S&P over 5 years, Joe Consorti notes
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc
CEOYing Choi Yu
Employees1.92K
Founded2000
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteck-lifesciences.com